Comparative effects of desflurane and isoflurane on vecuronium-induced neuromuscular blockade
- PMID: 1347223
- DOI: 10.1016/0952-8180(92)90117-j
Comparative effects of desflurane and isoflurane on vecuronium-induced neuromuscular blockade
Abstract
Study objective: To evaluate the neuromuscular effects of a nondepolarizing muscle relaxant (vecuronium) during anesthesia with equipotent concentrations of either desflurane or isoflurane.
Design: Randomized open study comparing effects of desflurane and isoflurane on vecuronium-induced neuromuscular blockade.
Setting: University-affiliated medical center.
Patients: Forty-five healthy adults undergoing elective surgical procedures randomly assigned to receive either desflurane, nitrous oxide (N2O), and vecuronium or isoflurane, N2O, and vecuronium for maintenance of general anesthesia.
Interventions: Following a standardized induction sequence, patients receiving either desflurane and N2O or isoflurane and N2O were administered bolus doses of vecuronium equal to 0.01, 0.02, or 0.03 mg/kg intravenously (IV) during the maintenance period. Neuromuscular transmission was measured using a Relaxograph monitor.
Measurements and main results: Vecuronium produced similar depression of neuromuscular function at equipotent (50% of the minimum alveolar concentration) end-tidal concentrations of isoflurane 0.6% and desflurane 3.0%. Following administration of vecuronium 0.01 to 0.03 mg/kg IV, onset times (3.4 +/- 0.4 minutes to 3.2 +/- 0.4 minutes and 3.2 +/- 0.5 minutes to 3.0 +/- 0.6 minutes), maximum T1 twitch depression (80% +/- 10% to 95% +/- 9% and 81% +/- 9% to 97% +/- 10%), clinical duration of blockade (12 +/- 5 minutes to 20 +/- 8 minutes and 10 +/- 5 minutes to 19 +/- 17 minutes), and T1 recovery times (10 +/- 3 minutes to 12 +/- 6 minutes and 10 +/- 3 minutes to 12 +/- 4 minutes) were similar in the isoflurane and desflurane treatment groups, respectively (means +/- SD).
Conclusion: Vecuronium has similar neuromuscular effects when administered in the presence of desflurane 3% and isoflurane 0.6%.
Similar articles
-
Adaptive feedback-controlled infusion versus repetitive injections of vecuronium in patients during isoflurane anesthesia.J Clin Anesth. 1991 May-Jun;3(3):181-5. doi: 10.1016/0952-8180(91)90156-h. J Clin Anesth. 1991. PMID: 1678941 Clinical Trial.
-
Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.Anesth Analg. 1996 Oct;83(4):818-22. doi: 10.1097/00000539-199610000-00029. Anesth Analg. 1996. PMID: 8831328 Clinical Trial.
-
A comparison of desflurane and isoflurane in prolonged surgery.J Clin Anesth. 1993 Mar-Apr;5(2):122-8. doi: 10.1016/0952-8180(93)90139-6. J Clin Anesth. 1993. PMID: 8476618
-
Desflurane potentiates atracurium in humans: a comparative study with isoflurane.J Clin Anesth. 1992 Nov-Dec;4(6):448-54. doi: 10.1016/0952-8180(92)90217-o. J Clin Anesth. 1992. PMID: 1457111 Clinical Trial.
-
[Comparison of the effect of desflurane and isoflurane on neuromuscular blockage with vecuronium on geriatric patients].Anaesthesiol Reanim. 1996;21(1):4-10. Anaesthesiol Reanim. 1996. PMID: 8901178 Clinical Trial. German.
Cited by
-
Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.Drugs. 1995 Oct;50(4):742-67. doi: 10.2165/00003495-199550040-00010. Drugs. 1995. PMID: 8536556 Review.
-
Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.Drug Saf. 1994 Jun;10(6):420-38. doi: 10.2165/00002018-199410060-00002. Drug Saf. 1994. PMID: 7917072 Review.
-
Desflurane clinical pharmacokinetics and pharmacodynamics.Clin Pharmacokinet. 1994 Jul;27(1):6-18. doi: 10.2165/00003088-199427010-00002. Clin Pharmacokinet. 1994. PMID: 7955772 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources